Major advances have occurred in the diagnosis and treatment of lymphoma in recent years. Our understanding of the molecular biology and genetics of the disease has increased exponentially, and significant imaging developments have resulted in earlier and more accurate diagnosis. The new edition of this landmark text places these advances in the context of daily clinical practice. Each chapter has been updated to reflect recent developments, including new treatment agents such as immunomodulatory drugs and the next generation of antibodies, and the increasing prognostic role of PET scanning. Results from recent large-scale clinical trials are presented, and pathology and cytogenetics are integrated into discussion of each disease entity, enabling the reader to review all the key diagnostic information in one place. Featuring many color illustrations, and written and edited by leading authorities in the field, Lymphoma provides all the information you need to diagnose and manage these complex disorders.
- Treatment algorithms for each lymphoma subtype guide you through the decision-making process for first- and second-line treatment
- Integrated pathology and cytogenetic information enable readers to review all of the key diagnostic information of each entity in a single place
- Highly illustrated in color throughout
Table of Contents
1. Epidemiology Eve Roman and Alexandra G. Smith
2. Prognostic factors for lymphomas Guillaume Cartron and Philippe Solal-Céligny
3. Imaging Heok K. Cheow and Ashley S. Shaw
4. Clinical trials in lymphoma Thomas M. Habermann and Matthew Maurer
5. Hodgkin lymphoma Stephanie Sasse and Andreas Engert
6. Follicular lymphoma Kristian Bowles
7. MALT and other marginal zone lymphomas Emanuele Zucca and Francesco Bertoni
8. Small lymphocytic lymphoma/chronic lymphocytic leukemia Peter Hillmen, with contributions from Andrew Wotherspoon, Andreas Rosenwald and German Ott
9. Waldenstrom's macroglobinemia/lymphoplasmacytic lymphoma Steven P. Treon and Giampaolo Merlini
10. Mantle cell lymphoma Martin Dreyling and Michael E. Williams
11. Burkitt and lymphoblastic lymphoma: clinical therapy and outcome Nirali N. Shah, Alan S. Wayne and Wyndham H. Wilson
12. Therapy of diffuse large B-cell lymphoma John W. Sweetenham
13. Central nervous system lymphomas Andrés J. M. Ferreri and Lisa M. DeAngelis
14. T-cell non-Hodgkin lymphoma Sheetal M. Kircher, Beverly P. Nelson, Steven T. Rosen and Andrew M. Evens
15. Primary cutaneous lymphoma Sean Whittaker
16. Lymphoma in the immunosuppressed Michele Spinaa, Robert Marcus, Shireen Kassam and Umberto Tirellia
17. Atypical lymphoproliferative, histiocytic and dendritic cell disorders Matthew S. Davids and Jennifer R. Brown
Robert Marcus, King's College London
Robert Marcus is a Consultant Haematologist at King's College Hospital NHS Foundation Trust, London, UK.
John W. Sweetenham, University of California, San Diego
John W. Sweetenham is Professor of Medicine and Medical Director, University of California, San Diego Nevada Cancer Institute, Las Vegas, NV, USA.
Michael E. Williams, University of Virginia School of Medicine, Charlottesville
Michael E. Williams is Byrd S. Leavell Professor of Medicine, Professor of Pathology and Director of the Hematologic Malignancies Section, Hematology/Oncology Division, University of Virginia School of Medicine, Charlottesville, VA, USA.